These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12526561)

  • 41. Synthesis and characterisation of mixed ligand Pt(II) and Pt(IV) oxadiazoline complexes.
    Sarju J; Arbour J; Sayer J; Rohrmoser B; Scherer W; Wagner G
    Dalton Trans; 2008 Oct; (39):5302-12. PubMed ID: 18827937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reaction of polynuclear platinum antitumor compounds with reduced glutathione studied by multinuclear (1H, 1H-15N gradient heteronuclear single-quantum coherence, and 195Pt) NMR spectroscopy.
    Oehlsen ME; Qu Y; Farrell N
    Inorg Chem; 2003 Sep; 42(18):5498-506. PubMed ID: 12950196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reactions of papain and of low-molecular-weight thiols with some aromatic disulphides. 2,2'-Dipyridyl disulphide as a convenient active-site titrant for papain even in the presence of other thiols.
    Brocklehurst K; Little G
    Biochem J; 1973 May; 133(1):67-80. PubMed ID: 4721623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of a platinum(iv) prodrug model by sulfur containing biological reductants: computational mechanistic elucidation.
    Chipman A; Yates BF; Canty AJ; Ariafard A
    Chem Commun (Camb); 2018 Sep; 54(74):10491-10494. PubMed ID: 30159577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photoactivatable diazido Pt(IV) anticancer complex can bind to and oxidize all four nucleosides.
    Cheng Y; Zhang J; Wu K; Gao F; Cheng Y; Zou T; Wu X; Zhao Y; Wang F
    Dalton Trans; 2020 Dec; 49(47):17157-17163. PubMed ID: 33244530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetics and mechanism for reversible chloride transfer between mercury(II) and square-planar platinum(II) chloro ammine, aqua, and sulfoxide complexes. Stabilities, spectra, and reactivities of transient metal-metal bonded platinum-mercury adducts.
    Gröning O; Sargeson AM; Deeth RJ; Elding LI
    Inorg Chem; 2000 Sep; 39(19):4286-94. PubMed ID: 11196924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanistic insight into protonolysis and cis-trans isomerization of benzylplatinum(II) complexes assisted by weak ligand-to-metal interactions. A combined kinetic and DFT study.
    Guido E; D'Amico G; Russo N; Sicilia E; Rizzato S; Albinati A; Romeo A; Plutino MR; Romeo R
    Inorg Chem; 2011 Mar; 50(6):2224-39. PubMed ID: 21341750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reaction of cis- and trans-[PtCl2(NH3)2] with reduced glutathione inside human red blood cells, studied by 1H and 15N-[1H] DEPT NMR.
    Berners-Price SJ; Kuchel PW
    J Inorg Biochem; 1990 Apr; 38(4):327-45. PubMed ID: 2332767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanistic elucidation of linker and ancillary ligand substitution reactions in Pt(II) dinuclear complexes.
    Ongoma PO; Jaganyi D
    Dalton Trans; 2013 Feb; 42(8):2724-34. PubMed ID: 23223554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The trans influence in the modulation of platinum anticancer agent biology: the effect of nitrite leaving group on aquation, reactions with S-nucleophiles and DNA binding of dinuclear and trinuclear compounds.
    Montero EI; Zhang J; Moniodis JJ; Berners-Price SJ; Farrell NP
    Chemistry; 2010 Aug; 16(30):9175-85. PubMed ID: 20589847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.
    Dedon PC; Borch RF
    Biochem Pharmacol; 1987 Jun; 36(12):1955-64. PubMed ID: 2954556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction of cis,trans,cis-[PtCl2(OCOCH3)2(NH3)2] by aqueous extracts of cancer cells.
    Nemirovski A; Kasherman Y; Tzaraf Y; Gibson D
    J Med Chem; 2007 Nov; 50(23):5554-6. PubMed ID: 17949066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reactivity of thiols towards derivatives of 2- and 6-methyl-1,4-naphthoquinone bioreductive alkylating agents.
    Wilson I; Wardman P; Lin TS; Sartorelli AC
    Chem Biol Interact; 1987 Mar; 61(3):229-40. PubMed ID: 3568193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid reduction of tetrachloro(D,L-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in RPMI 1640 tissue culture medium.
    Gibbons GR; Wyrick S; Chaney SG
    Cancer Res; 1989 Mar; 49(6):1402-7. PubMed ID: 2924297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of the chloride concentration on ligand substitution reactions of [Pt(SMC)Cl(2)] with biologically relevant nucleophiles.
    Soldatović T; Bugarcić ZD; van Eldik R
    Dalton Trans; 2009 Jun; (23):4526-31. PubMed ID: 19488451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line.
    Mauldin SK; Gibbons G; Wyrick SD; Chaney SG
    Cancer Res; 1988 Sep; 48(18):5136-44. PubMed ID: 3409241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A complete kinetic study of GG versus AG plantination suggests that the doubly aquated derivatives of cisplatin are the actual DNA binding species.
    Legendre F; Bas V; Kozelka J; Chottard JC
    Chemistry; 2000 Jun; 6(11):2002-10. PubMed ID: 10894399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts.
    Kasherman Y; Sturup S; Gibson D
    J Biol Inorg Chem; 2009 Mar; 14(3):387-99. PubMed ID: 19052781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New reduction pathways for ctc-[PtCl2(CH3CO2)2(NH3)(Am)] anticancer prodrugs.
    Nemirovski A; Vinograd I; Takrouri K; Mijovilovich A; Rompel A; Gibson D
    Chem Commun (Camb); 2010 Mar; 46(11):1842-4. PubMed ID: 20198227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toward supramolecular nanozymes for the photocatalytic activation of Pt(IV) anticancer prodrugs.
    Mazzei LF; Martínez Á; Trevisan L; Rosa-Gastaldo D; Cortajarena AL; Mancin F; Salassa L
    Chem Commun (Camb); 2020 Sep; 56(72):10461-10464. PubMed ID: 32910125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.